PRA acknowledges and thanks the members of the Rare Disease Advisory
Committee (RDAC) who provided their valuable contributions to the
development of these guidelines.
A Critical Success Factor in Rare Disease Clinical Research: Patient Advocacy Collaboration
In most public sectors, understanding the end user’s perspective and building out a product strategy around it is nothing short of dogma. However, in…